blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1592669

EP1592669 - SUBSTITUTED 2-AMINOIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR AS A DIAGNOSTIC REAGENT, AND MEDICAMENT CONTAINING THESE COMPOUNDS [Right-click to bookmark this link]
Former [2005/45]NOVEL SUBSTITUTED 2-AMINOIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR AS A DIAGNOSTIC REAGENT, AND MEDICAMENT CONTAINING THESE COMPOUNDS
[2007/17]
StatusNo opposition filed within time limit
Status updated on  22.08.2008
Database last updated on 14.09.2024
Most recent event   Tooltip25.02.2011Lapse of the patent in a contracting state
New state(s): IT		published on 30.03.2011  [2011/13]
Applicant(s)For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstraße 50
65929 Frankfurt am Main / DE
[N/P]
Former [2005/45]For all designated states
Sanofi-Aventis Deutschland GmbH
Brüningstrasse 50
65929 Frankfurt am Main / DE
Inventor(s)01 / HEINELT, Uwe
Mosbacher Strasse 54
65187 Wiesbaden / DE
02 / LANG, Hans-Jochen
Rüdesheimer Strasse 7
65719 Hofheim / DE
03 / HOFMEISTER, Armin
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt / DE
04 / WIRTH, Klaus
c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt / DE
05 / JANSEN, Hans-Willi
Distelweg 25
65527 Niedernhausen / DE
 [2007/04]
Former [2005/45]01 / HEINELT, Uwe
Mosbacher Strasse 54
65187 Wiesbaden / DE
02 / LANG, Hans-Jochen
Rüdesheimer Strasse 7
65719 Hofheim / DE
03 / HOFMEISTER, Armin
Pfaugasse 16
55276 Oppenheim / DE
04 / WIRTH, Klaus
Robert-Schumann-Ring 104
65830 Kriftel / DE
05 / JANSEN, Hans-Willi
Distelweg 25
65527 Niedernhausen / DE
Application number, filing date04703371.720.01.2004
[2005/45]
WO2004EP00394
Priority number, dateDE200310437404.02.2003         Original published format: DE 10304374
[2005/45]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO2004069806
Date:19.08.2004
Language:DE
[2004/34]
Type: A2 Application without search report 
No.:EP1592669
Date:09.11.2005
Language:DE
The application published by WIPO in one of the EPO official languages on 19.08.2004 takes the place of the publication of the European patent application.
[2005/45]
Type: B1 Patent specification 
No.:EP1592669
Date:17.10.2007
Language:DE
[2007/42]
Search report(s)International search report - published on:EP28.10.2004
ClassificationIPC:C07D233/50, C07D235/30, A61K31/4168, A61K31/4184, A61P1/10, A61P9/12, A61P11/16, A61P13/12, A61P33/02, A61P39/00
[2005/45]
CPC:
C07D233/50 (EP,US); A61P1/00 (EP); A61P1/10 (EP);
A61P1/16 (EP); A61P11/00 (EP); A61P11/16 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P25/00 (EP);
A61P25/08 (EP); A61P25/18 (EP); A61P25/20 (EP);
A61P25/22 (EP); A61P25/24 (EP); A61P3/00 (EP);
A61P3/06 (EP); A61P3/10 (EP); A61P3/12 (EP);
A61P33/00 (EP); A61P33/02 (EP); A61P33/06 (EP);
A61P33/14 (EP); A61P37/02 (EP); A61P39/00 (EP);
A61P43/00 (EP); A61P5/08 (EP); A61P7/00 (EP);
A61P7/02 (EP); A61P7/08 (EP); A61P9/00 (EP);
A61P9/02 (EP); A61P9/06 (EP); A61P9/10 (EP);
A61P9/12 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/45]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:SUBSTITUIERTE 2-AMINOIMIDAZOLE, VERFAHREN ZU IHRER HERSTELLUNG, IHRE VERWENDUNG ALS MEDIKAMENT ODER DIAGNOSTIKUM SOWIE DIESE ENTHALTENDES MEDIKAMENT[2007/17]
English:SUBSTITUTED 2-AMINOIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR AS A DIAGNOSTIC REAGENT, AND MEDICAMENT CONTAINING THESE COMPOUNDS[2007/17]
French:2-AMINO-IMIDAZOLES SUBSTITUES, PROCEDES DE PREPARATION CORRESPONDANTS ET UTILISATION COMME MEDICAMENT OU COMME AGENT DIAGNOSTIQUE ET MEDICAMENT LES CONTENANT[2007/17]
Former [2005/45]SUBSTITUIERTE 2-AMINOIMIDAZOLE, VERFAHREN ZU IHRER HERSTELLUNG, IHRE VERWENDUNG ALS MEDIKAMENT ODER DIAGNOSTIKUM SOWIE SIE ENTHALTENDES MEDIKAMENT
Former [2005/45]NOVEL SUBSTITUTED 2-AMINOIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS A MEDICAMENT OR AS A DIAGNOSTIC REAGENT, AND MEDICAMENT CONTAINING THESE COMPOUNDS
Former [2005/45]NOUVEAUX 2-AMINO-IMIDAZOLES SUBSTITUES, PROCEDES DE PREPARATION CORRESPONDANTS ET UTILISATION COMME MEDICAMENT OU COMME AGENT DIAGNOSTIQUE ET MEDICAMENT LES CONTENANT
Entry into regional phase05.09.2005National basic fee paid 
05.09.2005Designation fee(s) paid 
05.09.2005Examination fee paid 
Examination procedure19.08.2004Request for preliminary examination filed
International Preliminary Examining Authority: EP
20.07.2005Amendment by applicant (claims and/or description)
05.09.2005Examination requested  [2005/45]
11.04.2006Despatch of a communication from the examining division (Time limit: M04)
13.06.2006Reply to a communication from the examining division
23.04.2007Communication of intention to grant the patent
03.09.2007Fee for grant paid
03.09.2007Fee for publishing/printing paid
Divisional application(s)EP07014956.2  / EP1857445
Opposition(s)18.07.2008No opposition filed within time limit [2008/39]
Fees paidRenewal fee
31.01.2006Renewal fee patent year 03
31.01.2007Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY17.10.2007
CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
TR17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
AT20.01.2008
LU20.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
IT31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
HU18.04.2008
[2011/13]
Former [2010/38]CY17.10.2007
CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
TR17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
AT20.01.2008
LU20.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
HU18.04.2008
Former [2010/34]CY17.10.2007
CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
AT20.01.2008
LU20.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
HU18.04.2008
Former [2010/33]CY17.10.2007
CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
AT20.01.2008
LU20.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
Former [2009/35]CY17.10.2007
CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
AT20.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
Former [2009/23]CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
AT20.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
Former [2009/11]CZ17.10.2007
DK17.10.2007
EE17.10.2007
FI17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
GR18.01.2008
ES28.01.2008
BE31.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
Former [2008/48]CZ17.10.2007
DK17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
ES28.01.2008
CH31.01.2008
LI31.01.2008
MC31.01.2008
PT17.03.2008
Former [2008/45]CZ17.10.2007
DK17.10.2007
IE17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
ES28.01.2008
MC31.01.2008
PT17.03.2008
Former [2008/39]CZ17.10.2007
DK17.10.2007
NL17.10.2007
RO17.10.2007
SI17.10.2007
SK17.10.2007
BG17.01.2008
SE17.01.2008
ES28.01.2008
MC31.01.2008
PT17.03.2008
Former [2008/35]CZ17.10.2007
DK17.10.2007
NL17.10.2007
SI17.10.2007
BG17.01.2008
SE17.01.2008
ES28.01.2008
PT17.03.2008
Former [2008/26]NL17.10.2007
SI17.10.2007
BG17.01.2008
SE17.01.2008
ES28.01.2008
PT17.03.2008
Former [2008/24]NL17.10.2007
BG17.01.2008
SE17.01.2008
ES28.01.2008
PT17.03.2008
Cited inInternational search[X]US4275072  (KARJALAINEN ARTO, et al) [X] 1-10,17,23 * column 1, line 18 - line 19 ** Spalte 3, Formel (II) *;
 [DX]WO0246169  (AVENTIS PHARMA GMBH [DE]) [DX] 1-40 * Seite 1, Formel I * * page 22, line 14 - line 31 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.